Shareholders to Vote on Doubling Authorized Common Stock, Paving Way for Over 250% Potential Dilution

summarizeSummary

United States Antimony Corp. is asking shareholders to approve a massive increase in authorized common stock, potentially leading to over 250% dilution, while also disclosing past late insider trading filings.

check_boxKey Events

• Proposal to Significantly Increase Authorized Common Stock

  The company proposes to increase authorized common stock from 250,000,000 to 500,000,000 shares. With 143,039,365 shares currently outstanding, this creates potential for 356,960,635 additional shares. If all authorized shares were issued, dilution would be 250.93% relative to current outstanding shares. The company cites a need for flexibility in future financings, acquisitions, and equity compensation.

• Executive Compensation Disclosed

  Chairman and CEO Gary C. Evans's total compensation for 2025 was $5,038,488, with 'Compensation Actually Paid' reported as $10,065,988.

• Late Insider Trading Filings Noted

  The filing discloses that several directors and executive officers, including Gary C. Evans, Lloyd Joseph Bardswich, General (Ret.) John M. Keane, and Jon R. Marinelli, filed Forms 3 and 4 late in an earlier fiscal period, though all delinquent reports were subsequently filed.

• Routine Annual Meeting Proposals

  Shareholders will also vote on the election of seven directors and the ratification of Assure CPA, LLC as the independent registered public accounting firm for fiscal year 2026.

auto_awesomeAnalysis

United States Antimony Corp. is seeking shareholder approval to significantly increase its authorized common stock from 250 million to 500 million shares. With 143,039,365 shares currently outstanding, this proposed increase creates headroom for an additional 356,960,635 shares. If all authorized shares were issued, dilution would be 250.93% relative to current outstanding shares. The company states this is necessary for future equity-based financings, acquisitions, strategic joint ventures, and equity compensation, indicating a clear intent to utilize this capital. This substantial potential dilution could significantly impact existing shareholder value. Additionally, the filing discloses multiple instances of late insider trading reports (Forms 3 and 4) by several key executives and directors in prior periods, raising governance concerns, although these were subsequently filed. This comes after the 2025 annual report disclosed material weaknesses, suggesting a potential need for capital despite strong revenue growth.